What Has Driven the Growth of the Virology Specimen Collection Market in Recent Years?
The virology specimen collection market has seen considerable growth due to a variety of factors.
• In the past few years, the virology specimen collection market has seen substantial growth. The market value is projected to increase from $6.6 billion in 2024 to $6.98 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%.
The notable growth during the historic period is a result of occurrences such as disease outbreaks and pandemics, initiatives in public health and infectious disease research, quality control and regulations, and the rise in remote and home testing.
What is the Market Size Forecast for the Virology Specimen Collection Market?
The virology specimen collection market is expected to maintain its strong growth trajectory in upcoming years.
• It is anticipated that the virology specimen collection market will experience substantial growth in the coming years, expanding to a market size of $8.84 billion by 2029 with a compound annual growth rate (CAGR) of 6.1%.
The predicted growth during this forecast period could be due to global health readiness, the infrastructure available to respond to pandemics, surveillance and monitoring programs, as well as government funding and grants, alongside the increase in rapid diagnostic tests. Key trends forecasted for this period encompass self-collection kits, specimen collection at the point-of-care, integrated specimen collection devices, and advancements in digital health platforms, including telemedicine and e-health.
What Factors Are Driving Growth In The Virology Specimen Collection Market?
The uptick in blood donations worldwide has been contributing to the expansion of the virology specimen collection market. As the number of blood samples escalates, so does the need for examination and detection of viruses using the method of virology specimen collection. To illustrate, the World Health Organization (WHO), a Switzerland-situated specialized agency of the United Nations that handles international public health, stated in June 2023 that roughly 118.54 million blood donations were received across the globe. Around 40% of these donations were made in high-income nations, representing roughly 16% of the total global populace. It was stated that around 13,300 blood centers from 169 nations reported a cumulative collection of 106 million donations. Given these circumstances, it's anticipated that the demand for virology specimen collection will experience a rising trend, as blood donations continue to increase in number.
What Are The Main Segments Of The Global Virology Specimen Collection Market?
The virology specimen collection market covered in this report is segmented –
1) By Product Type: Blood Collection Kits, Specimen Collection Tubes, Viral Transport Media, Swabs
2) By Sample: Blood Samples, Nasopharyngeal Samples, Throat Samples, Nasal Samples, Cervical Samples, Oral Samples, Other Samples
3) Method: Manual, Automated
4) Application: Diagnostic, Therapeutic
Subsegments:
1) By Blood Collection Kits: Vacuum Blood Collection Tubes, Syringe Blood Collection Kits
2) By Specimen Collection Tubes: EDTA Tubes, Serum Separation Tubes, Heparin Tubes
3) By Viral Transport Media: Liquid Media, Dry Media
4) By Swabs: Nasopharyngeal Swabs, Oropharyngeal Swabs, Urethral Swabs
Pre-Book The Virology Specimen Collection Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Virology Specimen Collection Market?
Technological progress is revolutionizing the market for virology specimen collection. Advances in technology, which range from automatic specimen isolation to real-time amplification technology, have facilitated the creation and release of systems for most clinically important viruses and the collection of clinically significant information for efficient antiviral treatment solutions. For instance, Nightingale Health Plc, a health tech firm based in Finland, introduced a remote blood collection kit for its medical research and clinical trial customers in August 2023. Through the use of the Nightingale Kit and its self-collection instrument, clinical trial participants can collect their own blood sample with a simple finger prick. This significantly enhances the flexibility and broadens the possibilities for studies that were previously limited by logistical and geographical barriers. Additionally, remote blood gathering can be smoothly and economically embedded into research as Nightingale Health provides both the collection and analysis of samples.
Who Are the Key Players in the Virology Specimen Collection Market?
Major companies operating in the virology specimen collection market include:
• Puritan Medical Products Co. LLC
• Becton Dickinson and Company
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Trinity Biotech plc
• DiaSorin S.p.A.
• Vircell S.L.
• Copan Italia S.p.A.
• Hardy Diagnostics
• Laboratory Corporation of America Holdings
• ZeptoMetrix Corporation
• Copan Diagnostics Inc.
• Bionote Inc.
• F. Hoffmann-La Roche Ltd
• Meridian Bioscience Inc.
• Hologic Inc.
• Cepheid Inc.
• Bio-Rad Laboratories Inc.
• GenMark Diagnostics Inc.
• Luminex Corporation
• Abbott Laboratories
• BioFire Diagnostics LLC
• Randox Laboratories Ltd.
• Savyon Diagnostics Ltd.
• Seegene Inc.
• Serosep Ltd.
• SolGent Co. Ltd.
• TECOmedical AG
• Vela Diagnostics
• Zybio Inc.
What Is The Most Dominant Region In The Virology Specimen Collection Market?
North America was the largest region in the virology specimen collection market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virology specimen collection market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
